247 related articles for article (PubMed ID: 19564411)
1. Receptor density is key to the alpha2/beta interferon differential activities.
Moraga I; Harari D; Schreiber G; Uzé G; Pellegrini S
Mol Cell Biol; 2009 Sep; 29(17):4778-87. PubMed ID: 19564411
[TBL] [Abstract][Full Text] [Related]
2. Basal expression levels of IFNAR and Jak-STAT components are determinants of cell-type-specific differences in cardiac antiviral responses.
Zurney J; Howard KE; Sherry B
J Virol; 2007 Dec; 81(24):13668-80. PubMed ID: 17942530
[TBL] [Abstract][Full Text] [Related]
3. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
4. Virus Multiplicity of Infection Affects Type I Interferon Subtype Induction Profiles and Interferon-Stimulated Genes.
Zaritsky LA; Bedsaul JR; Zoon KC
J Virol; 2015 Nov; 89(22):11534-48. PubMed ID: 26355085
[TBL] [Abstract][Full Text] [Related]
5. STAM and Hrs interact sequentially with IFN-α Receptor to control spatiotemporal JAK-STAT endosomal activation.
Zanin N; Viaris de Lesegno C; Podkalicka J; Meyer T; Gonzalez Troncoso P; Bun P; Danglot L; Chmiest D; Urbé S; Piehler J; Blouin CM; Lamaze C
Nat Cell Biol; 2023 Mar; 25(3):425-438. PubMed ID: 36797476
[TBL] [Abstract][Full Text] [Related]
6. Activity of hybrid type I interferons in cells lacking Tyk2: a common region of IFN-alpha 8 induces a response, but IFN-alpha2/8 hybrids can behave like IFN-beta.
Platis D; Foster GR
J Interferon Cytokine Res; 2003 Nov; 23(11):655-66. PubMed ID: 14651780
[TBL] [Abstract][Full Text] [Related]
7. Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2.
Marijanovic Z; Ragimbeau J; van der Heyden J; Uzé G; Pellegrini S
Biochem J; 2007 Oct; 407(1):141-51. PubMed ID: 17627610
[TBL] [Abstract][Full Text] [Related]
8. IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7.
Sancéau J; Hiscott J; Delattre O; Wietzerbin J
Oncogene; 2000 Jul; 19(30):3372-83. PubMed ID: 10918594
[TBL] [Abstract][Full Text] [Related]
9. ISG12a inhibits HCV replication and potentiates the anti-HCV activity of IFN-α through activation of the Jak/STAT signaling pathway independent of autophagy and apoptosis.
Chen Y; Jiao B; Yao M; Shi X; Zheng Z; Li S; Chen L
Virus Res; 2017 Jan; 227():231-239. PubMed ID: 27777077
[TBL] [Abstract][Full Text] [Related]
10. An interferon alpha2 mutant optimized by phage display for IFNAR1 binding confers specifically enhanced antitumor activities.
Kalie E; Jaitin DA; Abramovich R; Schreiber G
J Biol Chem; 2007 Apr; 282(15):11602-11. PubMed ID: 17310065
[TBL] [Abstract][Full Text] [Related]
11. Respirovirus C protein inhibits activation of type I interferon receptor-associated kinases to block JAK-STAT signaling.
Kitagawa Y; Yamaguchi M; Kohno M; Sakai M; Itoh M; Gotoh B
FEBS Lett; 2020 Mar; 594(5):864-877. PubMed ID: 31705658
[TBL] [Abstract][Full Text] [Related]
12. Down-modulation of type 1 interferon responses by receptor cross-competition for a shared Jak kinase.
Dondi E; Pattyn E; Lutfalla G; Van Ostade X; Uzé G; Pellegrini S; Tavernier J
J Biol Chem; 2001 Dec; 276(50):47004-12. PubMed ID: 11602573
[TBL] [Abstract][Full Text] [Related]
13. Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta.
Jaitin DA; Roisman LC; Jaks E; Gavutis M; Piehler J; Van der Heyden J; Uze G; Schreiber G
Mol Cell Biol; 2006 Mar; 26(5):1888-97. PubMed ID: 16479007
[TBL] [Abstract][Full Text] [Related]
14. Role of the intracellular domain of the human type I interferon receptor 2 chain (IFNAR2c) in interferon signaling. Expression of IFNAR2c truncation mutants in U5A cells.
Russell-Harde D; Wagner TC; Rani MR; Vogel D; Colamonici O; Ransohoff RM; Majchrzak B; Fish E; Perez HD; Croze E
J Biol Chem; 2000 Aug; 275(31):23981-5. PubMed ID: 10825167
[TBL] [Abstract][Full Text] [Related]
15. Differences in activity between alpha and beta type I interferons explored by mutational analysis.
Runkel L; Pfeffer L; Lewerenz M; Monneron D; Yang CH; Murti A; Pellegrini S; Goelz S; Uzé G; Mogensen K
J Biol Chem; 1998 Apr; 273(14):8003-8. PubMed ID: 9525899
[TBL] [Abstract][Full Text] [Related]
16. Type I IFN receptor controls activated TYK2 in the nucleus: implications for EAE therapy.
Ahmed CM; Noon-Song EN; Kemppainen K; Pascalli MP; Johnson HM
J Neuroimmunol; 2013 Jan; 254(1-2):101-9. PubMed ID: 23110939
[TBL] [Abstract][Full Text] [Related]
17. Interferon alpha activates NF-kappaB in JAK1-deficient cells through a TYK2-dependent pathway.
Yang CH; Murti A; Valentine WJ; Du Z; Pfeffer LM
J Biol Chem; 2005 Jul; 280(27):25849-53. PubMed ID: 15883164
[TBL] [Abstract][Full Text] [Related]
18. IFN-alpha beta secreted during infection is necessary but not sufficient for negative feedback regulation of IFN-alpha beta signaling by Mycobacterium tuberculosis.
Prabhakar S; Qiao Y; Canova A; Tse DB; Pine R
J Immunol; 2005 Jan; 174(2):1003-12. PubMed ID: 15634924
[TBL] [Abstract][Full Text] [Related]
19. Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture.
Kurt R; Chandra PK; Aboulnasr F; Panigrahi R; Ferraris P; Aydin Y; Reiss K; Wu T; Balart LA; Dash S
PLoS One; 2015; 10(5):e0125962. PubMed ID: 25961570
[TBL] [Abstract][Full Text] [Related]
20. Emodin potentiates the antiproliferative effect of interferon α/β by activation of JAK/STAT pathway signaling through inhibition of the 26S proteasome.
He Y; Huang J; Wang P; Shen X; Li S; Yang L; Liu W; Suksamrarn A; Zhang G; Wang F
Oncotarget; 2016 Jan; 7(4):4664-79. PubMed ID: 26683360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]